November 21st, 2026Beyond the Skin: How Inflammation Connects Dermatologic DiseaseDermNexus 2026 experts explored systemic inflammation, skin-gut connections, cancer risk, and multidisciplinary care in dermatologic disease.Read more
November 21st, 2026DermNexus 2026 Day 1 Recap: Emerging Therapies and Clinical InsightsDermNexus 2026 Day 1 explored emerging therapies, immune pathways, and treatment advances in CSU, atopic dermatitis, vitiligo, and HS.Read more
November 20th, 2026Q&A: Where Skin Cancer Prevention Falls Short, With Leigh Ann Pansch, NPLeigh Ann Pansch, MSN, FNP-BC, DCNP, discusses year-round sun protection, missed skin cancer detection, and patient counseling for Healthy Skin Month.Read more
November 20th, 2026Gene Expression Profiling and Adjuvant Radiation Decisions in CSCCAt a Dermatology Times Case-Based Roundtable event moderated by Gaurav Singh, MD, MPH, clinicians discussed whether 40-GEP results change radiation, imaging, and follow-up in high-risk cutaneous squamous cell carcinoma.Read more
November 20th, 2026DermNexus 2026 to Explore Innovations in Inflammatory Skin DiseasePreview DermNexus 2026, featuring emerging dermatology therapies, inflammatory disease management, systemic comorbidities, and APP education.Read more
November 20th, 2026Guselkumab in Axial Psoriatic Arthritis: Phase 4 STAR Trial ResultsGuselkumab improved axial symptoms and MRI-assessed sacroiliac joint inflammation vs placebo in axial psoriatic arthritis in the phase 4 STAR trial.Read more
November 19th, 2026Experts Explore Individualized Treatment Strategies for PsoriasisExperts explore individualized plaque psoriasis treatment, highlighting biologic selection, adherence, comorbidities, and patient-centered care.Read more
November 19th, 2026Q&A: What Phase 2 Nemolizumab Data Mean for Young Children With EczemaA pediatric dermatologist explains how to read itch, sleep, and quality-of-life findings from phase 2 nemolizumab data in children aged 2 - 11.Read more